Seed Round of Capital

RxData raises a seed round of capital led by 8 international angel investors with strong expertise in the pharmaceutical market access environment. Notably, RxData investors span the globe from San Francisco and New York all the way to Switzerland and China. About RxData, Inc. (RxData) RxData, with operations in the U.S.A. and Switzerland, is a leading global market access data company, providing fast and reliable insights on life science commercialization. With the largest on-demand and automated database of pharmaceutical product prices and reimbursement decisions, it has never been easier to navigate the many complexities facing pharmaceutical commercialization. RxData empowers life science companies of all sizes to go-to-market faster, plan launches, price products and steer clinical and HEOR teams towards the best possible worldwide access.